Benzinga's Microcap Movers for Thursday November 1, 2012

Below are highlights from Benzinga's daily coverage of small cap and microcap securities making big moves:

Shares of Warp 9

, the Santa Barbara, CA provider of e-commerce services for midsize online sellers, rose 500% Thursday on 17.5 million shares. Warp 9 CFO Greg Boden told Benzinga there was no company news released to account for the move, but acknowledged that he did notice the stock was being promoted by a penny stock service. Boden said he gets about one call a week from interested buyers but no deal has been made. He did say the company does has some things in the works, but nothing has been made public. Warp 9 closed at $0.04 on Thursday.

Amarantus BioSciences

, the Sunnyvale, CA development-stage biotechnology company, rose 158% Thursday on 49 times average volume. Amarantus BioSciences announced Thursday that it intends to pursue the identification of one or multiple therapeutic indications for its lead therapeutic candidate MANF that could lead to the therapy receiving orphan drug designation(s) with the Food and Drug Administration (FDA). The strategy is centred on exploiting MANF's unique mechanism of action related to facilitating proper protein folding and processing in the endoplasmic reticulum in order to identify rare and/or ultra-rare diseases where MANF treatment may play a significant role in improving patient outcomes in disease states where no other treatment options are currently available. Amarantus BioSciences closed at $0.02 on Thursday.

Shares of China Advanced Construction Materials Group

, the China-based producer of advanced, certified eco-friendly ready-mix concrete, rose 62.98% Thursday on 13.5 times average volume. China Advanced Construction Materials Group shares rose following a strong China PMI report. China Advanced Construction Materials Group closed at $0.70 on Thursday.